Prospective Evaluation of AI R&D Tool for Patient Stratification - MoA Evaluation in Triple Negative Breast Cancer (PEAR-MET)
Clinical trial NCT06182306 · UNKNOWN
Trial details
- NCT number
- NCT06182306
- Sponsor
- Ourotech, Inc.
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-04-30
- Primary completion
- 2025-09-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.